ASVRX | PCVAX | ASVRX / PCVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 28 years | - |
Gain YTD | 4.327 | 11.646 | 37% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.58B | 316M | 1,765% |
Annual Yield % from dividends | 0.47 | 2.15 | 22% |
Returns for 1 year | 6.29 | 3.73 | 169% |
Returns for 3 years | -3.43 | -7.11 | 48% |
Returns for 5 years | 33.69 | -2.46 | -1,368% |
Returns for 10 years | 23.23 | -43.73 | -53% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EXHAX | 25.83 | N/A | N/A |
Manning & Napier Pro-Blend Max Term S | |||
VKSEX | 10.85 | N/A | N/A |
Virtus KAR Small-Mid Cap Value C | |||
CIAOX | 46.30 | -0.16 | -0.34% |
Capital Advisors Growth Investor | |||
FMUAX | 14.97 | -0.07 | -0.47% |
Federated Hermes Muni and Stock Adv A | |||
ESPCX | 35.17 | -0.43 | -1.21% |
Allspring Special Small Cap Value C |